Acute alveolitis induced by hydroxyurea in a patient with myeloproliferative syndrome
- 1 September 1993
- journal article
- case report
- Published by Springer Nature in Annals of Hematology
- Vol. 67 (3) , 133-134
- https://doi.org/10.1007/bf01701737
Abstract
Hydroxyurea is increasingly being used to control myeloproliferative disorders, in part because of its relative lack of side effects. We present a case of life-threatening alveolitis in a patient treated with hydroxyurea for myeloproliferative syndrome. Absence of exposure to other drugs and the clinical course suggest that the alveolitis was induced by hydroxyurea.Keywords
This publication has 14 references indexed in Scilit:
- HYDROXYUREA-INDUCED TOXIC SIDE-EFFECTS IN ANIMALS AND AN ATTEMPT AT REDUCING THEM WITH VITAMIN-E AND VITAMIN-C1989
- Management of polycythaemia vera, essential thrombocythaemia and myelofibrosis with hydroxyurea*European Journal of Haematology, 1988
- HYDROXYUREA AS A CAUSE OF DRUG FEVER IN CHRONIC MYELOID-LEUKEMIA1988
- Hydroxyurea in the Treatment of Polycythemia Vera: A Prospective Study of 100 Patients Over a 20-Year PeriodSouthern Medical Journal, 1987
- Drug-induced pulmonary diseaseDisease-a-Month, 1987
- Fever Caused by HydroxyureaArchives of internal medicine (1960), 1981
- Severe reaction to hydroxyurea.1977
- Psoriasis With HydroxyureaArchives of Dermatology, 1973
- Psoriasis with hydroxyurea. An 18-month study of 60 patientsArchives of Dermatology, 1973